biuro@scopefluidics.com +48 22 376 21 14
enpl
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

Category

Uncategorized
05
Jun

Scope Fluidics publishes BacterOMIC’s operational objectives

05.06.2023
Read More
28
Apr

Most Influencing Person title for prof. Piotr Garstecki

28.04.2023
Read More
27
Apr

Prof. Piotr Garstecki with the title of Health Policy Authority

27.04.2023
Read More
31
Mar

Prof. Piotr Garstecki on the cover of Forbes magazine!

31.03.2023
Read More
31
Mar

Scope Fluidics in the top class of the capital market according to the Stock Exchange and Investors Gazette “Parkiet”

31.03.2023
Read More
15
Mar

Scope Fluidics publishes Development Strategy

15.03.2023
Read More
Prof. Garstecki Scope Fluidics
08
Mar

What happens if we run out of antibiotics? Prof. Piotr Garstecki at Cordis European Commision portal

08.03.2023
Read More
08
Mar

BacterOMIC achieves Patent for Microfluidic Chip in Chinese Market

08.03.2023
Read More
21
Feb

Scope Fluidics’ Management Board recommends payment of PLN 85.57 per share in the form of a dividend, which implies a dividend yield of approximately 30%

21.02.2023
Read More
20
Jan

Scope Fluidics debuted on the Main Market at Warsaw Stock Exchange

20.01.2023
Read More
1 … 4 5 6 7 8 … 14

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.

Recent Comments

    Tag Cloud

    home